SEC62 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6286971771251E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.63327162694804E-12 |
Normal-vs-Stage2 |
4.73130000000488E-06 |
Normal-vs-Stage3 |
5.64779999989717E-07 |
Normal-vs-Stage4 |
1.62725388719309E-12 |
Stage1-vs-Stage2 |
4.996200E-01 |
Stage1-vs-Stage3 |
5.652800E-01 |
Stage1-vs-Stage4 |
3.241900E-03 |
Stage2-vs-Stage3 |
8.972800E-01 |
Stage2-vs-Stage4 |
2.057000E-01 |
Stage3-vs-Stage4 |
1.215410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.29172236743125E-12 |
Normal-vs-AfricanAmerican |
3.66373598126302E-15 |
Normal-vs-Asian |
1.94990000002004E-06 |
Caucasian-vs-AfricanAmerican |
3.82130000000647E-05 |
Caucasian-vs-Asian |
2.338400E-01 |
AfricanAmerican-vs-Asian |
8.014600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
2.85929999999102E-06 |
Male-vs-Female |
3.855000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.71129998639242E-09 |
Normal-vs-Age(41-60Yrs) |
9.03621621972661E-12 |
Normal-vs-Age(61-80Yrs) |
9.04054608952265E-13 |
Normal-vs-Age(81-100Yrs) |
2.398100E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.092000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.446600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.402400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.386600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.295000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.034400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.311000E-01 |
Normal-vs-Grade 2 |
1.13169995596962E-09 |
Normal-vs-Grade 3 |
3.13948866903502E-12 |
Normal-vs-Grade 4 |
1.62492241884138E-12 |
Grade 1-vs-Grade 2 |
2.747600E-01 |
Grade 1-vs-Grade 3 |
1.421170E-01 |
Grade 1-vs-Grade 4 |
2.183400E-03 |
Grade 2-vs-Grade 3 |
4.891700E-02 |
Grade 2-vs-Grade 4 |
1.198140E-04 |
Grade 3-vs-Grade 4 |
3.934000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.56059999999658E-05 |
Normal-vs-ccB subtype |
3.2532865290591E-12 |
ccA subtype-vs-ccB subtype |
2.13109999999128E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.28009960806719E-10 |
Normal-vs-N1 |
5.83739999671096E-08 |
N0-vs-N1 |
2.297200E-01 |
|
|